SatheeshChonatMD

Associate Professor, Department of Pediatrics, Emory University and Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta

Dr. Chonat is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1405 Clifton Rd NE
Atlanta, GA 30322
Phone+1 404-785-1112

Fax+1 404-785-6288

Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Hematology/Oncology, 2012 - 2015
Sparrow HospitalResidency, Pediatrics, 2009 - 2012
Cambridge University Hospitals and London School of PaediatricsSpeciality Training Registrar, General Pediatrics, Neonatology and Hematology/Oncology, 2003 - 2009
M.S. Ramaiah Medical CollegeClass of 2003

PubMed

6 citations
Frequency of HLA-DRCD38T cells identifies and quantifies T-cell activation in hemophagocytic lymphohistiocytosis, hyperinflammation, and immune regulatory disorders.
Thinh H Nguyen, Deepak Kumar, Chengyu Prince, Dylan Martini, Jocelyn R Grunwell
The Journal of Allergy and Clinical Immunology. 2024-01-01
41 citations
Extracellular fluid tonicity impacts sickle red blood cell deformability and adhesion.
Marcus A. Carden, Meredith E. Fay, Xinran Lu, Robert G. Mannino, Yumiko Sakurai
Blood. 2017-12-14
5 citations
Congenital dyserythropoietic anemia type I: First report from the Congenital Dyserythropoietic Anemia Registry of North America (CDAR)
Omar Niss, Robert B. Lorsbach, Mikaela Berger, Satheesh Chonat, Morgan L. McLemore
Blood Cells, Molecules & Diseases. 2021-03-01

Abstracts/Posters

Congenital Dyserythropoietic Anemia Type I Due to Biallelic CDAN1 mutations: Report from the Congenital Dyserythropoietic Anemia Registry (CDAR)
Satheesh Chonat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Comorbidities and Complications in Adults with Pyruvate Kinase Deficiency
Satheesh Chonat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Characterization of the Severe Phenotype of Pyruvate Kinase Deficiency
Satheesh Chonat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Pyruvate Kinase (PK) Protein and Enzyme Levels in the Diagnosis and Clinical Phenotype of PK Deficiency
Satheesh Chonat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Join now to see all

Rezurock Approved for Chronic Graft-vs-Host DiseaseAugust 4th, 2021
Ultomiris Approved for Pediatric Patients with Paroxysmal Nocturnal HemoglobinuriaJune 8th, 2021
Alexion Announces FDA Approval of ULTOMIRIS® (Ravulizumab-Cwvz) for Children and Adolescents with Paroxysmal Nocturnal Hemoglobinuria (PNH)June 7th, 2021